Tools for SARS-CoV-2 Research

BioLegend wants to help in your fight against COVID-19

BioLegend is dedicated to helping accelerate the development of diagnostic tests, therapeutics, and vaccines for SARS-CoV-2. If you would like BioLegend to review a potential partnership or a collaboration for your research, please tell us how we can support your work and provide us with a projected timeline.

SARS-CoV-2 Workflow

Viral Recognition and Inflammation

Viral entry and the resulting inflammation are key mechanisms under investigation by SARS-CoV-2 researchers. We provide SARS-CoV-2 recombinant proteins and antibodies to investigate the interactions between S1 spike protein and human ACE2 for viral entry. Our ELISA kits and LEGENDplex™ assays can further characterize early inflammation and the efficacy of interventions by tracking the cytokine response. By fully understanding the virus’ starting point and its subsequent effects on the body, we can dismantle SARS-CoV-2 before it has a chance to even start.

Antibodies

  • Anti-human ACE2
  • Anti-human CD304 (Neuropilin-1)
  • Anti-mouse CD304 (Neuropilin-1)
  • Anti-SARS-CoV-2 Nucleocapsid
  • Anti-SARS-CoV-2 S Protein S1
  • Anti-SARS-Cov-2 S Protein S2

Recombinant Proteins

  • Biotinylated Recombinant SARS-CoV-2 S Protein RBD
  • Biotinylated Recombinant SARS-CoV-2 S Protein S1
  • Recombinant Human ACE2
  • Recombinant Human Neuropilin-1
  • Recombinant Mouse ACE2
  • Recombinant SARS-CoV-2 S Protein RBD
  • Recombinant SARS-CoV-2 S Protein S1
  • Recombinant SARS-CoV-2 S Protein S1+S2
  • Recombinant SARS-CoV-2 S Protein S1+S2 (R683A, R685A)

Featured ELISA Kits and Sets

  • SARS-CoV-2 Spike Protein Antibodies
  • SARS-CoV-2 Nucleocapsid Protein
  • Interferons
  • Cytokines/Chemokines

Featured LEGENDplex™ Panels

  • SARS-CoV-2 Spike Protein Antibodies
  • SARS-CoV-2 Nucleocapsid Protein
  • Interferons
  • Cytokines/Chemokines